[go: up one dir, main page]

GB0008332D0 - Treament - Google Patents

Treament

Info

Publication number
GB0008332D0
GB0008332D0 GBGB0008332.9A GB0008332A GB0008332D0 GB 0008332 D0 GB0008332 D0 GB 0008332D0 GB 0008332 A GB0008332 A GB 0008332A GB 0008332 D0 GB0008332 D0 GB 0008332D0
Authority
GB
United Kingdom
Prior art keywords
treament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0008332.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER Ltd
Pfizer Ltd Great Britain
Original Assignee
PFIZER Ltd
Pfizer Ltd Great Britain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER Ltd, Pfizer Ltd Great Britain filed Critical PFIZER Ltd
Priority to GBGB0008332.9A priority Critical patent/GB0008332D0/en
Publication of GB0008332D0 publication Critical patent/GB0008332D0/en
Priority to US09/818,403 priority patent/US6521647B2/en
Priority to MXPA02009819A priority patent/MXPA02009819A/es
Priority to PCT/IB2001/000518 priority patent/WO2001074390A2/en
Priority to BR0109783-0A priority patent/BR0109783A/pt
Priority to EP01914134A priority patent/EP1284719A2/en
Priority to AU2001239510A priority patent/AU2001239510A1/en
Priority to JP2001572132A priority patent/JP2003528927A/ja
Priority to CA002403950A priority patent/CA2403950A1/en
Priority to PE2001000305A priority patent/PE20011163A1/es
Priority to ARP010101580A priority patent/AR027763A1/es
Priority to TNTNSN01051A priority patent/TNSN01051A1/fr
Priority to PA20018514601A priority patent/PA8514601A1/es
Priority to US10/210,229 priority patent/US20030109557A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0008332.9A 2000-04-04 2000-04-04 Treament Ceased GB0008332D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB0008332.9A GB0008332D0 (en) 2000-04-04 2000-04-04 Treament
US09/818,403 US6521647B2 (en) 2000-04-04 2001-03-27 Treatment of renal disorders
CA002403950A CA2403950A1 (en) 2000-04-04 2001-03-28 Treatment of renal disorders
AU2001239510A AU2001239510A1 (en) 2000-04-04 2001-03-28 Treatment of renal disorders
PCT/IB2001/000518 WO2001074390A2 (en) 2000-04-04 2001-03-28 The use of a calcium channel blocker for treating renal disorders
BR0109783-0A BR0109783A (pt) 2000-04-04 2001-03-28 Tratamento de doenças renais
EP01914134A EP1284719A2 (en) 2000-04-04 2001-03-28 The use of a calcium channel blocker for treating renal disorders
MXPA02009819A MXPA02009819A (es) 2000-04-04 2001-03-28 El uso de un bloqueante de los canales de calcio para tratamiento de trastornos renales.
JP2001572132A JP2003528927A (ja) 2000-04-04 2001-03-28 腎機能障害の処置
PE2001000305A PE20011163A1 (es) 2000-04-04 2001-04-02 Tratamiento de trastornos renales
ARP010101580A AR027763A1 (es) 2000-04-04 2001-04-03 Tratamiento de trastornos renales
TNTNSN01051A TNSN01051A1 (fr) 2000-04-04 2001-04-03 Formes posologiques d'agents de blocage du canal calcium pour le traitement de maladies renales
PA20018514601A PA8514601A1 (es) 2000-04-04 2001-04-03 Tratamiento de trastornos renales
US10/210,229 US20030109557A1 (en) 2000-04-04 2002-07-31 Treatment of renal disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0008332.9A GB0008332D0 (en) 2000-04-04 2000-04-04 Treament

Publications (1)

Publication Number Publication Date
GB0008332D0 true GB0008332D0 (en) 2000-05-24

Family

ID=9889228

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0008332.9A Ceased GB0008332D0 (en) 2000-04-04 2000-04-04 Treament

Country Status (12)

Country Link
EP (1) EP1284719A2 (es)
JP (1) JP2003528927A (es)
AR (1) AR027763A1 (es)
AU (1) AU2001239510A1 (es)
BR (1) BR0109783A (es)
CA (1) CA2403950A1 (es)
GB (1) GB0008332D0 (es)
MX (1) MXPA02009819A (es)
PA (1) PA8514601A1 (es)
PE (1) PE20011163A1 (es)
TN (1) TNSN01051A1 (es)
WO (1) WO2001074390A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7335380B2 (en) 2000-12-29 2008-02-26 Synthon Ip Inc. Amlodipine free base
AU2001294354A1 (en) * 2000-12-29 2002-07-16 Bioorganics B.V. Process for making amlodipine, derivatives thereof, and precursors therefor
AT5874U1 (de) * 2000-12-29 2003-01-27 Bioorg Bv Pharmazeutische zubereitungen enthaltend amlodipinmaleat
CN1298317C (zh) * 2001-11-07 2007-02-07 斯索恩有限公司 坦洛新片剂
NL1019882C2 (nl) * 2002-02-01 2003-08-04 Synthon Licensing Amlodipine vrije base.
CO5400144A1 (es) * 2002-03-11 2004-05-31 Novartis Ag Compuestos organicos
JP4418753B2 (ja) * 2002-09-30 2010-02-24 興和株式会社 腎疾患の予防及び治療用医薬組成物
WO2004067003A1 (ja) 2003-01-31 2004-08-12 Sankyo Company, Limited 動脈硬化及び高血圧症の予防及び治療のための医薬
US20080268049A1 (en) * 2005-02-11 2008-10-30 Dhaliwal Mona Stable Solid Dosage Forms of Amlodipine and Benazepril
US10130624B2 (en) 2005-03-15 2018-11-20 Lupin Limited Pharmaceutical compositions of amlodipine and benazepril
AU2006242463A1 (en) * 2005-04-29 2006-11-09 Hill's Pet Nutrition, Inc. Methods for prolonging feline life
CA3015964C (en) * 2016-03-24 2021-08-03 Daiichi Sankyo Company, Limited Medicine for treating renal disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8710493D0 (en) * 1987-05-02 1987-06-03 Pfizer Ltd Dihydropyridines
ATE113839T1 (de) * 1990-05-31 1994-11-15 Pfizer Arzneimittel gegen impotenz.
NZ242724A (en) * 1991-05-15 1994-09-27 Du Pont Synergistic composition comprising an angiotensin-ii receptor antagonist and a calcium channel blocker
WO1993010779A1 (en) * 1991-11-26 1993-06-10 Sepracor, Inc. Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
ES2193233T3 (es) * 1995-03-16 2003-11-01 Pfizer Uso de amiodipina, una sal de la misma o felodipina en combinacion con un inhibidor ace en la fabricacion de un medicamento para el tratamiento de insuficiencia cardiaca conjuntiva no isquemica.
EP0795327A1 (en) * 1996-03-13 1997-09-17 Pfizer Inc. Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin

Also Published As

Publication number Publication date
EP1284719A2 (en) 2003-02-26
MXPA02009819A (es) 2003-03-27
TNSN01051A1 (fr) 2005-11-10
WO2001074390A3 (en) 2002-05-30
AU2001239510A1 (en) 2001-10-15
WO2001074390A2 (en) 2001-10-11
PE20011163A1 (es) 2001-11-12
PA8514601A1 (es) 2002-08-26
CA2403950A1 (en) 2001-10-11
AR027763A1 (es) 2003-04-09
JP2003528927A (ja) 2003-09-30
BR0109783A (pt) 2003-01-21

Similar Documents

Publication Publication Date Title
GB2364651B (en) Golf-putters
IL151319A0 (en) Pyridinylimidazoles
HUP0302221A3 (en) 4-amino-quinazolines
DE50107703D1 (en) Creatininsensor-kalibration
DE50112014D1 (en) Stiftheizer
GB0025222D0 (en) Snugglefresh
GB0008332D0 (en) Treament
DE50114303D1 (en) Nsaugluftkanal
AU9187601A (en) Triazolo-epothilones
GB0016454D0 (en) Thienopyrrolidinones
GB0020749D0 (en) Calycins
GB0000430D0 (en) Tametip
GB2346550B (en) Multi-crib
GB0008333D0 (en) Treament
GB0029984D0 (en) Madona
GB0016119D0 (en) Ic2idu
GB0004984D0 (en) Rotagrip
GB0020889D0 (en) Ground-tamer
GB0007499D0 (en) Cubos
GB0007779D0 (en) Worder
GB0009354D0 (en) Diaminocyclobutenediones
GB0009534D0 (en) Escapeapparatus
GB0009545D0 (en) Corner-master
GB0009737D0 (en) Cryo-Electricity
GB0011230D0 (en) Dartcricket

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)